认知障碍的老年记忆门诊就诊者中2型糖尿病及糖化血红蛋白水平处于推荐目标范围内对死亡率的影响:NCGG-STORIES研究
本回顾性队列研究纳入记忆门诊就诊的1528例无2型糖尿病和468例有2型糖尿病的年龄≥65岁患者。有2型糖尿病者按糖化血红蛋白(HbA1c)水平、认知功能、日常生活活动能力和低血糖高风险药物分为目标范围内、高于和低于三组。中位随访3.8年,353例(17.7%)死亡。与无2型糖尿病者相比,HbA1c高于目标范围(HR 1.70,95%CI 1.08-2.69)和低于目标范围(HR 2.15,95%CI 1.33-3.48)与更高死亡风险相关,而HbA1c处于目标范围内则无此关联(HR 1.02,95%CI 0.77-1.36)。
要点
- 与无2型糖尿病者相比,HbA1c高于目标范围者死亡风险更高(HR 1.70,95%CI 1.08-2.69)。
- 与无2型糖尿病者相比,HbA1c低于目标范围者死亡风险更高(HR 2.15,95%CI 1.33-3.48)。
- 与无2型糖尿病者相比,HbA1c处于目标范围内者死亡风险无显著差异(HR 1.02,95%CI 0.77-1.36)。
核心结论
- HbA1c高于和低于目标范围与更高的死亡风险相关,而HbA1c处于目标范围内的患者与无2型糖尿病者相比未表现出更高的死亡风险。
- 这些结果为当前针对认知障碍老年人的目标范围提供了经验性支持。
研究设计与样本
- 本回顾性队列研究纳入记忆门诊就诊的年龄≥65岁患者,其中无2型糖尿病者1528例、有2型糖尿病者468例。
- 468例2型糖尿病患者根据HbA1c水平、认知功能、日常生活活动能力和低血糖高风险药物分为HbA1c目标范围内、高于目标范围和低于目标范围三组。
- 采用Cox比例风险模型评估糖尿病及HbA1c水平对死亡率的影响。
主要发现
- 中位随访3.8年期间,353例(17.7%)死亡。
- 与无2型糖尿病者相比,HbA1c高于目标范围者死亡风险更高(HR 1.70,95%CI 1.08-2.69)。
- 与无2型糖尿病者相比,HbA1c低于目标范围者死亡风险更高(HR 2.15,95%CI 1.33-3.48)。
- 与无2型糖尿病者相比,HbA1c处于目标范围内者死亡风险无显著差异(HR 1.02,95%CI 0.77-1.36)。
关键数值与推荐
- 目标范围依据日本糖尿病学会/日本老年医学会联合委员会推荐。
- 与无2型糖尿病者相比,HbA1c高于目标范围者HR 1.70(95%CI 1.08-2.69)。
- 与无2型糖尿病者相比,HbA1c低于目标范围者HR 2.15(95%CI 1.33-3.48)。
- 与无2型糖尿病者相比,HbA1c处于目标范围内者HR 1.02(95%CI 0.77-1.36)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the impact of type 2 diabetes and glycated hemoglobin (HbA1c) levels within the recommended target range according to the Japan Diabetes Society/Japan Geriatrics Society Joint Committee on mortality in older adults with cognitive impairment. RESEARCH DESIGN AND METHODS: This retrospective cohort study included 1,528 and 468 patients aged ≥65 years without and with type 2 diabetes, respectively, who were visiting a memory clinic. The 468 patients with type 2 diabetes were divided into three groups (within, above, and below the target range) based on their HbA1c levels, cognitive function, ability to perform activities of daily living, and medications associated with a high risk of hypoglycemia. The impact of diabetes and HbA1c levels on mortality was evaluated using Cox proportional hazards models. RESULTS: Over a median follow-up period of 3.8 years, 353 patients (17.7%) died. Compared with individuals without type 2 diabetes, HbA1c levels above (hazard ratio [HR] 1.70, 95% CI 1.08-2.69) and below (HR 2.15, 95% CI 1.33-3.48) the target range were associated with a higher risk of death; however, HbA1c levels within the target range were not (HR 1.02, 95% CI 0.77-1.36). CONCLUSIONS: HbA1c levels above and below the target range were associated with a higher risk of mortality, whereas patients with HbA1c levels within the target range did not exhibit a higher risk of mortality than individuals without type 2 diabetes. These results provide empirical support for the current target ranges among older adults with cognitive impairment.
引用
- Sugimoto T, Sakurai T, Uchida K, et al. Impact of Type 2 Diabetes and Glycated Hemoglobin Levels Within the Recommended Target Range on Mortality in Older Adults With Cognitive Impairment Receiving Care at a Memory Clinic: NCGG-STORIES. Diabetes Care. 2024. PMID: 38470970. doi:10.2337/dc23-2324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。